PubMed ID:
29563196
Public Release Type:
Journal
Publication Year: 2018
Affiliation: Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL.
DOI:
https://doi.org/10.2337/dc17-1779
Authors:
Senior PA,
Wang Y,
Abdulla MH,
Alejandro R,
Al-Saden P,
Alvarez Gil A,
Arreaza-Rubin G,
Balamurugan AN,
Barbaro B,
Bayman L,
Begley B,
Bellin MD,
Bigam DL,
Brandenburg M,
Bridges ND,
Campbell P,
Cano J,
Carpentier S,
Chaloner K,
Chen X,
Clarke WR,
Clinical Islet Transplantation Consortium,
Corrales AC,
Czarniecki CW,
Dalton-Bakes C,
Dillon JS,
Diltz C,
Dinyari P,
Doelle GC,
Ecklund D,
Eggerman TL,
Faradji R,
Feddersen D,
Feurer ID,
Foster ED,
Froud T,
Fu H,
Goldstein JS,
Green N,
Harmon JV,
Hecyk A,
Hering BJ,
Herrada E,
Hunsicker LG,
Hutchinson J,
Inverardi L,
Jasperson C,
Johnson K,
Kamoun M,
Kandaswamy R,
Kaufman DB,
Kearns J,
Kenyon N,
Khan A,
Kin T,
Kneteman NM,
Korsgren O,
Lafontant DE,
Larsen CP,
Linetsky E,
Liu C,
Li Y,
Loganathan G,
Luning-Prak E,
Luo X,
Luo Y,
Lyon J,
Malcolm A,
Markmann E,
Markmann JF,
Martellotto J,
McElroy J,
Min Z,
Molitch M,
Monson N,
Moreno J,
Mueller K,
Naji A,
Neill-Hudson T,
Nollen D,
Oberholzer J,
O'Gorman D,
Onderka C,
Owen R,
Palanjian M,
Papas KK,
Pawlick R,
Pedersen J,
Peixoto E,
Posselt AM,
Priore A,
Qidwai J,
Qi M,
Ramos M,
Richer B,
Rickels MR,
Ricordi C,
Riss H,
Robien MA,
Rojas T,
Rosichuk S,
Sarman D,
Schneider E,
Schroeder A,
Schwieger T,
Sears M,
Shapiro AMJ,
Shlansky-Goldberg R,
Stock PG,
Stuart E,
Szot G,
Toth L,
Toth V,
Turgeon NA,
Vivek K,
Wallia A,
Wang L,
Wang S,
Webster D,
Wilhelm JJ,
Willits J,
Witson J,
Yankey J,
Zhai W,
Zhang X,
Ziaie AS
Attaining glycemic targets without severe hypoglycemic events (SHEs) is a challenging treatment goal for patients with type 1 diabetes complicated by impaired awareness of hypoglycemia (IAH). The CIT Consortium Protocol 07 (CIT-07) trial showed islet transplantation to be an effective treatment for subjects with IAH and intractable SHEs. We evaluated health-related quality of life (HRQOL), functional health status, and health utility before and after pancreatic islet transplantation in CIT-07 trial participants.